Search Results

There are 12683 results for: content related to: Minocycline promotes axonal regeneration through suppression of RGMa in rat MCAO/reperfusion model

  1. Minocycline for acne vulgaris: efficacy and safety

    Intervention Review

    The Cochrane Library

    Sarah E Garner, Anne Eady, Cathy Bennett, John Norman Newton, Karen Thomas and Catalin Mihai Popescu

    Published Online : 15 AUG 2012, DOI: 10.1002/14651858.CD002086.pub2

  2. You have free access to this content
    Minocycline: far beyond an antibiotic

    British Journal of Pharmacology

    Volume 169, Issue 2, May 2013, Pages: 337–352, N Garrido-Mesa, A Zarzuelo and J Gálvez

    Version of Record online : 25 APR 2013, DOI: 10.1111/bph.12139

  3. Minocycline protects oligodendroglial precursor cells against injury caused by oxygen-glucose deprivation

    Journal of Neuroscience Research

    Volume 90, Issue 5, May 2012, Pages: 933–944, Thomas Schmitz, Stefanie Endesfelder, Li-Jin Chew, Irina Zaak and Christoph Bührer

    Version of Record online : 18 JAN 2012, DOI: 10.1002/jnr.22824

  4. You have free access to this content
    Cochrane Review: Minocycline for acne vulgaris: efficacy and safety

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 6, Issue 5, September 2011, Pages: 1440–1544, Sarah E Garner, Anne Eady, Catalin Mihai Popescu, John Newton and Alain Li Wan Po

    Version of Record online : 8 SEP 2011, DOI: 10.1002/ebch.853

  5. Evaluation of canine-specific minocycline and doxycycline susceptibility breakpoints for meticillin-resistant Staphylococcus pseudintermedius isolates from dogs

    Veterinary Dermatology

    Volume 26, Issue 5, October 2015, Pages: 334–e71, Melanie L. Hnot, Lynette K. Cole, Gwendolen Lorch, Mark G. Papich, Paivi J. Rajala-Schultz and Joshua B. Daniels

    Version of Record online : 28 JUL 2015, DOI: 10.1111/vde.12227

  6. Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats

    Acta Pharmacologica Sinica

    Volume 28, Issue 6, June 2007, Pages: 763–772, Li-sheng CHU, San-hua FANG, Yu ZHOU, Guo-liang YU, Meng-ling WANG, Wei-ping ZHANG and Er-qing WEI

    Version of Record online : 24 MAY 2007, DOI: 10.1111/j.1745-7254.2007.00578.x

  7. Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia-induced cerebellar hypoplasia in the Gunn rat

    European Journal of Neuroscience

    Volume 22, Issue 1, July 2005, Pages: 21–27, Suizhen Lin, Xing Wei, Kelly R. Bales, Aaron B. C. Paul, Zhizhong Ma, Guangmei Yan, Steven M. Paul and Yansheng Du

    Version of Record online : 19 JUL 2005, DOI: 10.1111/j.1460-9568.2005.04182.x

  8. Locally delivered minocycline microspheres for the treatment of periodontitis in smokers

    Journal of Clinical Periodontology

    Volume 30, Issue 9, September 2003, Pages: 787–794, David Paquette, Richard Oringer, Jan Lessem, Steven Offenbacher, Robert Genco, G. Rutger Persson, Edward A. Santucci and Ray C. Williams

    Version of Record online : 3 SEP 2003, DOI: 10.1034/j.1600-051X.2003.00375.x

  9. Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca2+ signalling in hippocampal neurons

    European Journal of Neuroscience

    Volume 26, Issue 9, November 2007, Pages: 2481–2495, José Carlos González, Javier Egea, María Del Carmen Godino, Francisco J. Fernandez-Gomez, José Sánchez-Prieto, Luís Gandía, Antonio G. García, Joaquín Jordán and Jesús M. Hernández-Guijo

    Version of Record online : 1 NOV 2007, DOI: 10.1111/j.1460-9568.2007.05873.x

  10. Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature

    British Journal of Dermatology

    Volume 166, Issue 6, June 2012, Pages: 1333–1341, B. Lebrun-Vignes, C. Kreft-Jais, A. Castot, O. Chosidow and the French Network of Regional Centers of Pharmacovigilance

    Version of Record online : 25 MAY 2012, DOI: 10.1111/j.1365-2133.2012.10845.x

  11. Pharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrations

    Equine Veterinary Journal

    Volume 44, Issue 4, July 2012, Pages: 453–458, L. V. SCHNABEL, M. G. PAPICH, T. J. DIVERS, C. ALTIER, M. S. APREA, T. M. McCARREL and L. A. FORTIER

    Version of Record online : 25 SEP 2011, DOI: 10.1111/j.2042-3306.2011.00459.x

  12. You have free access to this content
    Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis

    Journal of Neurochemistry

    Volume 105, Issue 5, June 2008, Pages: 1582–1595, Manoj Kumar Mishra and Anirban Basu

    Version of Record online : 18 JAN 2008, DOI: 10.1111/j.1471-4159.2008.05238.x

  13. Effect of feeding on the pharmacokinetics of oral minocycline in healthy research dogs

    Veterinary Dermatology

    Volume 26, Issue 6, December 2015, Pages: 399–e93, Melanie L. Hnot, Lynette K. Cole, Gwendolen Lorch, Paivi J. Rajala-Schultz and Mark G. Papich

    Version of Record online : 18 AUG 2015, DOI: 10.1111/vde.12246

  14. DOMINO, doxycycline 40mg vs minocycline 100mg in the treatment of rosacea: a randomised, single blinded, non-inferiority trial, comparing efficacy and safety

    British Journal of Dermatology

    Accepted manuscript online: 31 OCT 2016, M. M. D. van der Linden, A. R. van Ratingen, D. C. van Rappard, S. A. Nieuwenburg and Ph. I. Spuls

    DOI: 10.1111/bjd.15155

  15. Characterization of pigmented granules in minocycline-induced cutaneous pigmentation: observations using fluorescence microscopy and high-performance liquid chromatography

    British Journal of Dermatology

    Volume 129, Issue 4, October 1993, Pages: 403–407, N. OKADA, S. SATO, T. SASOU, M. AOYAMA, K. NISHIDA and K. YOSHIKAWA

    Version of Record online : 29 JUL 2006, DOI: 10.1111/j.1365-2133.1993.tb03166.x

  16. Minocycline can delay the development of morphine tolerance, but cannot reverse existing tolerance in the maintenance period of neuropathic pain in rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 1, January 2015, Pages: 94–101, Xin Zhang, Jing Wang, Tingting Yu, Dongping Du and Wei Jiang

    Version of Record online : 22 DEC 2014, DOI: 10.1111/1440-1681.12316

  17. You have free access to this content
    Effects of minocycline on Fas-mediated fulminant hepatitis in mice

    British Journal of Pharmacology

    Volume 144, Issue 2, January 2005, Pages: 275–282, Heng-Cheng Chu, Yi-Ling Lin, Huey-Kang Sytwu, Shin-Hua Lin, Ching-Len Liao and You-Chen Chao

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706079

  18. Effect of minocycline on inflammation-induced damage to the blood–brain barrier and white matter during development

    European Journal of Neuroscience

    Volume 26, Issue 12, December 2007, Pages: 3465–3474, H. B. Stolp, C. J. Ek, P. A. Johansson, K. M. Dziegielewska, A. M. Potter, M. D. Habgood and N. R. Saunders

    Version of Record online : 10 DEC 2007, DOI: 10.1111/j.1460-9568.2007.05973.x

  19. Minocycline attenuates hypoxia–ischemia-induced neurological dysfunction and brain injury in the juvenile rat

    European Journal of Neuroscience

    Volume 24, Issue 2, July 2006, Pages: 341–350, Lir-Wan Fan, Shuying Lin, Yi Pang, Philip G. Rhodes and Zhengwei Cai

    Version of Record online : 12 JUL 2006, DOI: 10.1111/j.1460-9568.2006.04918.x

  20. Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death

    Journal of Neuroscience Research

    Volume 90, Issue 3, March 2012, Pages: 682–690, Bernardino Ossola, Tiina A. Lantto, Katja A. Puttonen, Raimo K. Tuominen, Atso Raasmaja and Pekka T. Männistö

    Version of Record online : 23 NOV 2011, DOI: 10.1002/jnr.22791